The Largest Security-Cleared Career Network for Defense and Intelligence Jobs - JOIN NOW

Homeland Security

WHO Hopes Russia's Sputnik V Vaccine to Be Distributed Through COVAX Program

Sputnik News

05:36 GMT 09.02.2021(updated 07:54 GMT 09.02.2021)

GENEVA(Sputnik) - The World Health Organization (WHO) expressed hope, in its comment for Sputnik, that Russia's Sputnik V vaccine against the coronavirus would be distributed through the COVAX international program after receiving the WHO authorization for emergency use.

"We hope Gamaleya [research institute] will join Covax on the condition it receives WHO emergency use listing," the WHO said.

The WHO held a session to discuss additional data related to the Russian vaccine on Monday. The next round of negotiations is slated for 15 February.

Sputnik V, developed by the Gamaleya Epidemiology and Microbiology Center and registered by the Russian Ministry of Health on 11 August, was the world's first vaccine against the novel coronavirus. The vaccine consists of two components that are applied to a person within an interval of 21 days. The phase 3 trial included over 20,000 adult volunteers, and is still ongoing, as it aims at including 40,000 participants.

The Russian Direct Investment Fund, which promotes Sputnik V in international market, expects that the EU's regulator may approve the vaccine in early March.

© Sputnik



NEWSLETTER
Join the GlobalSecurity.org mailing list